Type and hit ENTER

ProAxsis specialises in four key areas of business:

Neutrophil Elastase Airways Test
  • Rapid point-of-care tests – NEATstik®, a lateral flow test for measuring active neutrophil elastase at point-of-care, was registered with a CE Mark in September 2017. Recently published data has shown that measuring active NE levels using NEATstik® enables identification of patients with airway bacterial infection and those patients at highest risk of suffering pulmonary exacerbations over the subsequent 12 months.
Clinical research services
Academic and Pharmaceutical Company Researchers
  • Our experienced team can provide a number of services for both academic and pharmaceutical company researchers, and are able to offer sample analysis at our purpose-built laboratory for a range of proteases and other inflammatory biomarkers.
ProAxsis R&D Projects
are supported by a variety of external partners
  • ProAxsis has a number of R&D projects ongoing, whch are supported by a variety of external partners. We are also able to conduct bespoke R&D projects at the request of academic groups or pharmaceutical companies.


ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, and a collaboration of the University of Geneva and the University Hospital of Geneva, today announce that they have reached agreement on a global licensing agreement.  Researchers at the University have developed a highly novel assay for a Cathepsin K-dependent periostin …

February 21, 2021

ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active proteases and other inflammatory biomarkers, today announces that it has appointed Hölzel Diagnostika as the first distributor of its portfolio of respiratory research assays in Europe. Based in Cologne and founded in 1993, Hölzel …

December 14, 2020

ProAxsis (www.proaxsis.com), the Belfast-based respiratory diagnostics company, today announces that it has been awarded a high impact Innovate UK grant as part of the recent “UKRI Ideas to Address COVID-19” competition.  The company will immediately initiate the £390,000 project, which will be co-funded by Innovate UK, to …

December 10, 2020
ProAxsis | developing products for the capture, detection and measurement of active protease biomarkers of disease